Identification of Polo-like kinase 1 interaction inhibitors using a novel cell-based assay
about
Current progress and future perspectives in the development of anti-polo-like kinase 1 therapeutic agents.Coupling of Polo kinase activation to nuclear localization by a bifunctional NLS is required during mitotic entry.Several inhibitors of the Plk1 Polo-Box Domain turn out to be non-specific protein alkylators.
P2860
Identification of Polo-like kinase 1 interaction inhibitors using a novel cell-based assay
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Identification of Polo-like ki ...... using a novel cell-based assay
@ast
Identification of Polo-like ki ...... using a novel cell-based assay
@en
type
label
Identification of Polo-like ki ...... using a novel cell-based assay
@ast
Identification of Polo-like ki ...... using a novel cell-based assay
@en
prefLabel
Identification of Polo-like ki ...... using a novel cell-based assay
@ast
Identification of Polo-like ki ...... using a novel cell-based assay
@en
P2093
P2860
P356
P1433
P1476
Identification of Polo-like ki ...... using a novel cell-based assay
@en
P2093
Alexandre Beautrait
Anne Marinier
Jean Duchaine
Jean-François Lavallée
Karine Normandin
Marie Futter
Sébastien Guiral
Vincent Archambault
P2860
P2888
P356
10.1038/SREP37581
P407
P577
2016-11-22T00:00:00Z
P6179
1019833056